Assessment of the Effect of Age on the Immunological and Virological Response to a Live Attentuated Influenza Vaccine for the 2009 H1N1 Virus

Trial Profile

Assessment of the Effect of Age on the Immunological and Virological Response to a Live Attentuated Influenza Vaccine for the 2009 H1N1 Virus

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Apr 2016 Time frame for primary endpoint changed from 'days 2,5, and 7' to 'day 0 to day 7 post vaccination'.
    • 02 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top